MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0068786
Janveda Formulation Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.86 Lakh
▼ 68% YoY
Net loss · FY 2025
₹5.35 Lakh
Net margin -19.2%
EBITDA · FY 2025
-₹97,480
EBITDA margin -3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹23 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Janveda Formulation Private Limited
Data last updated:
Janveda Formulation Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2019PTC105848. Its GSTIN is 24AAECJ4329C1ZZ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tusharbhai Babubhai Mangukiya and Prakashbhai Kalubhai Goti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed 54 Silver Industrial Estate – 2 Nr. Nova Industries Changodar, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.86 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹5.35 Lakh (net margin -19.2%) and EBITDA of -₹97,480 (EBITDA margin -3.5%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 15% over five years.
The company is associated with 1 brand: Janveda. As per MCA filings, the company has open charges of ₹23 Lakh on record.
Janveda Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0068786). For more details, the company can be reached via its website janveda.com.
Company details
CIN U74999GJ2019PTC105848
Registration Number 105848
Incorporation Date 03 January 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0068786
Recognitions & Rankings of Janveda Formulation
Contact details
Janveda Formulation Private Limited's registered office is in Ahmedabad, Gujarat. Its website is janveda.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShed 54 Silver Industrial Estate – 2 Nr. Nova Industries Changodar, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Janveda Formulation Private Limited, buy the company report.
Comprehensive company report
Janveda Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Janveda Formulation operates one associated brand: Janveda. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and distribution with a focus on healthcare values in India. | janveda.com |
Business activity
The main business activity of Janveda Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Janveda Formulation Private Limited, buy the company report.
Financials of Janveda Formulation Private Limited
FY 2025 filings availableJanveda Formulation Private Limited reported revenue of ₹27.86 Lakh (down 68% YoY) for FY 2025.
Revenue · FY 2025
₹27.86 Lakh ▼ 68%
Net loss · FY 2025
₹5.35 Lakh margin -19.2%
EBITDA · FY 2025
-₹97,480 margin -3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 33%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 126%
3 years · compounded
▼ 32%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 68% fall in the latest year. EBITDA fell 126% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,480 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.5% | ||||
| Net Profit Margin | -19.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Janveda Formulation Private Limited, buy the company report.
Board of directors of Janveda Formulation Private Limited
Janveda Formulation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tusharbhai Babubhai Mangukiya Also directs: Janveda Healthceutical Private Limited, Janveda Federation | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
| Prakashbhai Kalubhai Goti | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Janveda Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Newnano Technologies Private Limited | ₹28.03 Lakh (FY 2025) | -59.0% | Mumbai, Maharashtra, India | |||
| Rising Flora Biotech Private Limited | ₹27.99 Lakh (FY 2024) | 9.0% | Jalgaon, Maharashtra, India | |||
| Valasys Lifesciences Private Limited | ₹27.91 Lakh (FY 2024) | -10.0% | Pune, Maharashtra, India | |||
| Clear Gems Private Limited | ₹27.91 Lakh (FY 2025) | -39.0% | Mumbai, Maharashtra, India | |||
| Gale Pharma (India) Private Limited | ₹27.87 Lakh (FY 2020) | -67.0% | Hyderabad, Telangana, India | |||
| Janveda Formulation Private Limitedthis company | ₹27.86 Lakh (FY 2025) | -₹5.35 Lakh | -19.2% | -68.0% | Ahmedabad, Gujarat, India | |
| KRH Healthcare Private Limited | ₹27.84 Lakh (FY 2023) | -58.0% | Nashik, Maharashtra, India | |||
| Musita Health Care Private Limited | ₹27.83 Lakh (FY 2025) | -9.0% | Allahabad, Uttar Pradesh, India | |||
| Ceymco Global Private Limited | ₹27.81 Lakh (FY 2021) | 33.0% | Chennai, Tamil Nadu, India | |||
| Genovision Labs Private Limited | ₹27.79 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Pendulum Lifesciences Private Limited | ₹27.73 Lakh (FY 2018) | -24.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Janveda Formulation Private Limited, buy the company report.
Auditor
Janveda Formulation Private Limited is audited by Fenil P Shah and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Fenil P Shah and Associates | FY 2023 | 143571W |
Shareholding
The shareholding of Janveda Formulation Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Janveda Formulation Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2024 | 100937902 | Others | ₹23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Janveda Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Janveda Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Janveda Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECJ4329C1ZZ | Gujarat | Active | 29 Jan 2019 |
To see the full GST registrations and return filing status of Janveda Formulation Private Limited, buy the company report.
Recent activity
Janveda Formulation Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Mayur Natvarlal Devani ceased to be Additional Director on 01 Apr 2023.
AGM
Janveda Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Janveda Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 23.00 Lakh with Charge ID 100937902 was registered on 31 May 2024.
Ceased
Mayur Natvarlal Devani ceased to be Additional Director.
Appointed
Mayur Natvarlal Devani was appointed as Additional Director.
Appointed
Prakashbhai Kalubhai Goti was appointed as Director.
Appointed
Tusharbhai Babubhai Mangukiya was appointed as Director.
Incorporation
03 Jan 2019
Janveda Formulation Private Limited was registered on 03 Jan 2019 with Roc Ahmedabad & aged 7 years 9 months as per MCA records.
Frequently asked questions
Janveda Formulation is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U74999GJ2019PTC105848.
Janveda Formulation has 2 current directors:
- Tusharbhai Babubhai Mangukiya - Director
- Prakashbhai Kalubhai Goti - Director
The latest financial statements of Janveda Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Janveda Formulation is 24AAECJ4329C1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Janveda Formulation is U74999GJ2019PTC105848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Janveda Formulation was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Janveda Formulation by revenue are Newnano Technologies Private Limited, Rising Flora Biotech Private Limited, Valasys Lifesciences Private Limited, Clear Gems Private Limited, Gale Pharma (India) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayur Natvarlal Devani ceased to be Additional Director on 01 Apr 2023. Mayur Natvarlal Devani was appointed as Additional Director on 14 Nov 2022. Prakashbhai Kalubhai Goti was appointed as Director on 03 Jan 2019. Janveda Formulation has 4 board changes on record in total.
Yes, Janveda Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0068786).
Janveda Formulation can be reached through the website janveda.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Janveda Formulation is at Shed 54 Silver Industrial Estate – 2 Nr. Nova Industries Changodar, Ahmedabad, Gujarat, India – 382213.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages